WO2019172517A1 - 피부 피막 형성제 - Google Patents
피부 피막 형성제 Download PDFInfo
- Publication number
- WO2019172517A1 WO2019172517A1 PCT/KR2019/000169 KR2019000169W WO2019172517A1 WO 2019172517 A1 WO2019172517 A1 WO 2019172517A1 KR 2019000169 W KR2019000169 W KR 2019000169W WO 2019172517 A1 WO2019172517 A1 WO 2019172517A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- dimethicone
- agent
- hydride
- skin film
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/892—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a hydroxy group, e.g. dimethiconol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/612—By organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/651—The particulate/core comprising inorganic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/95—Involves in-situ formation or cross-linking of polymers
Definitions
- the present invention relates to a skin film forming agent.
- Skin improvement through physiological approach through such a functional ingredient is a problem that is difficult to blend quickly enough to produce a satisfactory effect due to the time-consuming and safety and stability problems in the cosmetic formulation.
- the use of such a coating agent is based on the idea that the film shrinks during drying during film formation, and the shrinking force pulls the fine wrinkles of the skin to increase the feeling of rubbing and temporarily removes the fine wrinkles.
- the coating agent polysaccharide, polyvinylpyrrolidone (PVP), polyvinyl alcohol (PVA), silicone coating agent, polyurethane material, etc. may be used, but silicone-based coating agent may exhibit properties similar to skin. There is no foreign matter, and it is an easy coating material in that it can easily adjust physical properties.
- Korean Patent Publication No. 10-2013-0135843 is a cross-linking of vinyl dimethicone used as a reaction enhancing component and hydride dimethicone used as a crosslinking component to form a film that can immediately improve wrinkles and body correction Although reported, the coating is easily peeled off due to the rolling phenomenon when applied to the skin has a disadvantage that it is difficult to last for a long time.
- the present invention is to provide a skin film-forming agent without safety problems, to form a high-strength coating to eliminate the peeling and sliding of the film and effectively improve the skin disadvantages, in particular wrinkles and elasticity.
- the present invention provides a skin film-forming agent comprising dimethiconol, hydride dimethicone and a crosslinking component.
- Skin coating agent according to an aspect of the present invention is characterized in that the dimethicone and hydride dimethicone is spatially separated before the crosslinking component and the skin is applied to prevent contact.
- the skin coating agent comprises i) a first agent comprising dimethicone and hydride dimethicone, and ii) a second agent comprising a crosslinking component, wherein the first agent and the second agent
- the agent is characterized in that it is mixed immediately before skin application and applied to the skin.
- Dimethiconol of the skin film-forming agent according to an aspect of the present invention has a viscosity of 1000 to 100000 cP or cSt, hydride dimethicone is characterized in that the viscosity of 0.1 to 1000 cP or cSt.
- Skin film forming agent according to an aspect of the present invention is characterized in that it comprises 0.1 to 30% (w / w) of dimethicone, 0.1 to 15% (w / w) of hydric dimethicone relative to the total weight of the former.
- Skin coating agent according to an aspect of the present invention is characterized in that the dimethicone: hydride dimethicone content of 1 to 4: 1.
- the hydride dimethicone of the skin film former according to one aspect of the present invention is characterized by having at least one hydride end.
- SiH content of the hydride dimethicone of the skin film-forming agent according to an aspect of the present invention is characterized in that 1 to 15 mmol / g.
- the crosslinking component of the skin film-forming agent according to an aspect of the present invention is characterized by catalyzing the in situ crosslinking reaction of dimethicone and hydride dimethicone.
- the skin film former according to an aspect of the present invention is characterized in that it comprises 0.1 to 5% (w / w) of the crosslinking component relative to the total weight of the skin film former.
- the crosslinking component of the skin film-forming agent according to one aspect of the present invention is characterized in that the platinum catalyst.
- Platinum catalyst of the skin coating agent is a platinum carbonyl cyclovinylmethylsiloxane complex, platinum divinyl tetramethyldisiloxane complex, platinum cyclovinylmethylsiloxane complex, platinum octanealdehyde / octanol complex and their It is characterized in that it is selected from the group consisting of combinations.
- Skin coating agent according to an aspect of the present invention is characterized in that it further comprises any one or more selected from the group consisting of surface treated mica, zinc oxide, titanium dioxide, aluminum oxide, clay and silica.
- Silica of the skin film-forming agent according to an aspect of the present invention is characterized in that the surface treatment with hexamethyldisilazane (Hexamethyldisilazane).
- the skin film forming agent according to an aspect of the present invention is characterized by preventing skin wrinkles and sagging, delaying skin wrinkles and sagging, improving skin wrinkles and sagging, enhancing skin elasticity, providing skin moisture, and providing skin vitality.
- the present invention provides a skin film-forming agent that can form a high-strength coating, eliminates peeling and slipping of the coating, and effectively improves skin disadvantages, particularly wrinkles and elasticity.
- 1 is a visual evaluation of wrinkle improvement of the skin film-forming agent according to an embodiment of the present invention.
- Figure 2 is a result confirming the improvement of the pushed phenomenon of the skin film-forming agent according to an embodiment of the present invention.
- the present invention for achieving the above object is characterized by a skin film-forming agent comprising a dimethiconol, a hydride dimethicone (Hydride dimethicone) and a crosslinking component.
- a skin film-forming agent comprising a dimethiconol, a hydride dimethicone (Hydride dimethicone) and a crosslinking component.
- the present invention provides a skin film-forming agent comprising dimethiconol, hydride dimethicone and a crosslinking component.
- skin coating agent of the present invention is a preparation for forming a film for improving skin defects on the skin, and includes a cosmetic preparation.
- the dimethiconol may be, for example, dimethylsiloxane having a hydroxyl group as a terminal and may have a structure of the following formula.
- n may be 450 to 3000, preferably 500 to 2750, more preferably 550 to 2500.
- the dimethiconol is a polymer having a molecular weight of about 26000 to 175000 Da or less, specifically 29000 to 160000 Da, more specifically 32000 to 145000 Da.
- the hydride dimethicone is a polysiloxane having hydrogen as a terminal and may have, for example, a structure of the following formula.
- n is 0 to 35, preferably m is 0 to 300, n is 0 to 30, more preferably m is 0 to 300 and n may be 0 to 25.
- the hydride dimethicone is a polymer having a molecular weight of about 200 to 30000 Da, specifically 300 to 25000 Da, more specifically 400 to 20000 Da.
- dimethicone and hydride dimethicone may be spatially separated before the crosslinking component and the skin is applied to prevent contact.
- crosslinking component of the present invention is a component that induces in situ formation between dimethicone and hydride dimethicone, which causes condensation of these elements so that a film is formed on the skin.
- the skin coating agent of the present invention comprises i) a first agent comprising dimethicone and hydride dimethicone, and ii) a second agent comprising a crosslinking component, wherein the first
- the second and second agents may be mixed and applied to the skin just prior to skin application. That is, the dimethicone and hydride dimethicone forming the coating structure of the present invention and the crosslinking component catalyzing the reaction thereof are prevented from being spatially separated and brought into contact before use. Dimethicone and hydride dimethicone and crosslinking components can be brought into contact prior to use by common means known to those skilled in the art.
- a first agent comprising dimethicone and hydride dimethicone and a second agent comprising a crosslinking component are two part formulations which are packaged in separate containers and mixed prior to use.
- a first agent comprising dimethicone and hydride dimethicone is applied, and a second agent comprising a crosslinking component is applied on the first agent.
- a second agent comprising a crosslinking component is first applied to the skin and a first agent comprising dimethicone and hydride dimethicone is applied over the second agent.
- a first agent comprising dimethicone and hydride dimethicone and a second agent comprising a crosslinking component are packaged together in the same container with a barrier between the two formulations and when the component exits the container. Are mixed.
- viscosity refers to the measurement of the resistance of a fluid in which deformation occurs by either shear stress or tensile stress. Viscosity can be either dynamic viscosity (absolute viscosity, conventional units Pa ⁇ s, Poise, P, cP) or kinematic viscosity (typically cm 2 / s, Stokes, St, cSt) divided by density Can be represented. Therefore, when the density of the fluid is about 1, the dynamic viscosity and the kinematic viscosity are almost equivalent. Those skilled in the art will appreciate that the viscosity can vary with temperature and pressure and that such measurements can be adjusted as appropriate.
- a viscometer or a rheometer
- capillary viscometers, rotational viscometers, or rheometers can be used to measure viscosity in certain strain instruments.
- a Viscometer BROOKFIELD Co., Ltd.
- the dimethiconol may have a viscosity of 1000 to 100000 cP or cSt, preferably 10000 to 90000 cP or cSt, more preferably 20000 to 80000 cP or cSt (25 ° C.).
- the dimethiconol having a constant viscosity is composed only of the dimethiconol of a suitable molecular weight having the same viscosity as the final viscosity, or a high viscosity dimethiconol having a high molecular weight and a low viscosity dimethicol having a low molecular weight
- the cornol can be mixed and provided as appropriate.
- the hydride dimethicone may have a viscosity of 0.1 to 1000 cP or cSt, preferably 0.5 to 800 cP or cSt, more preferably 1 to 600 cP or cSt (25 ° C.).
- the hydride dimethicone having a constant viscosity is composed only of a hydride dimethicone of a suitable molecular weight having the same viscosity as the final viscosity, or a high viscosity high hydride dimethicone and a high molecular weight Low, low viscosity hydride dimethicone can be mixed and provided as appropriate.
- the content of dimethiconol is 0.1 to 30% (w / w), specifically 5 to 25% (w / w), more specifically 10 to 10, based on the total weight of the skin film former. 20% (w / w). In one example, the dimethiconol content in the skin film former is 15% (w / w).
- the content of the hydride dimethicone is 0.1 to 15% (w / w), specifically 3 to 12% (w / w), more specifically 5 to 10 compared to the skin coating agent It may be% (w / w).
- the dimethiconol content in the skin film former is 7% (w / w).
- the skin coating agent of the present invention may have a dimethicone: hydride dimethicone content of 1 to 4: 1, specifically 2 to 3: 1.
- the hydride dimethicone may have at least one or more hydride ends.
- it may have two hydride groups at both ends, and 0 to 20, specifically 0 to 12, more specifically 0 to 8 Si-H units in the monomer unit.
- the SiH content of the hydride dimethicone may be 1 to 15 mmole / g, specifically 2 to 12 mmole / g, more specifically 4 to 10 mmole / g, most specifically 6 To 9 mmole / g.
- the crosslinking component of the skin coating agent of the present invention may catalyze the in situ crosslinking reaction of dimethicone and hydride dimethicone. That is, the hydroxyl group terminal of the dimethicone of the present invention and the hydrogen terminal of the hydride dimethicone are bonded to each other while generating hydrogen (see Scheme below).
- the film formation by the combination of the conventional vinyl silicon and hydride dimethicone has been widely used as a material for shaping teeth because there is almost no degree of shrinkage of the film because there is no by-product generated by the reaction.
- the reaction according to the present invention is not only high shrinkage force during the film formation by the reaction of hydrogen generated in the film formation process, but also a high strength film is formed is effective in improving wrinkles and elasticity.
- the hydroxyl group at the end of dimethiconol acts as a factor that enhances the adhesion by hydrogen bonding with keratin of the stratum corneum of the skin to be firmly fixed without being pushed after applying the skin to improve water resistance and durability.
- the content of the crosslinking component is 0.1 to 5% (w / w), specifically 0.2 to 3% (w / w), more specifically 0.5 to 2% (w /) compared to the skin coating agent w).
- the crosslinking component of the skin coating agent of the invention is a metal catalyst, in particular a platinum catalyst, more specifically platinum carbonyl cyclovinylmethylsiloxane complex, platinum divinyltetramethyldisiloxane complex, platinum cyclo Vinylmethylsiloxane complexes, platinum octaaldehyde / octanol complexes, and combinations thereof.
- a metal catalyst in particular a platinum catalyst, more specifically platinum carbonyl cyclovinylmethylsiloxane complex, platinum divinyltetramethyldisiloxane complex, platinum cyclo Vinylmethylsiloxane complexes, platinum octaaldehyde / octanol complexes, and combinations thereof.
- the skin coating agent of the present invention may further comprise an enhancer component to provide the coating with desirable properties.
- the reinforcing agent that can be used in the present invention, it may further include any one or more selected from the group consisting of surface treated mica, zinc oxide, titanium dioxide, aluminum oxide, clay and silica.
- the silica may be fumed silica, and the fumed silica may be surface treated with hexamethyldisilazane.
- the enhancer component has a surface area of about 50 to about 400 m 2 / g, specifically about 110 to about 330 m 2 / g, more specifically about 170 to about 270 m 2 / g.
- the reinforcing component has a surface area of about 220 ⁇ 25 m 2 / g.
- the enhancer component has an average particle size of about 1 to about 500 nm.
- the skin coating agent of the present invention is a tactile modifier, spreading agent, adhesion modifier, diluent, adhesive modifier, optical modifier, particles, volatile siloxane, emulsifier, emollient, surfactant, thickener, solvent, film It may further include any one or more selected from the group consisting of a forming agent, a humectant, a preservative and a pigment.
- the skin encapsulating agent of the present invention can mask, alleviate, ameliorate or inhibit various skin defects.
- skin defect refers to a dark red nevus or flaming nevus (eg, nape flaming nevus or midline flaming nevus), blemishes, wrinkles, blemishes, acne, moles, scars, tattoos, bruises, skin damage, birthmarks, sun damage, aging damage, non-uniform skin tone, sagging skin, rough skin, hyperpigmentation, enlarged pores, capillary dilatation, redness, gloss, cellulite, pregnancy lines or loss of skin elasticity.
- the skin encapsulation agent of the present invention masks any one or more skin defects selected from wrinkles, pigmentation, blotch, increased pores, scarring, decreased elasticity, sagging, reduced moisture and reduced gloss of the skin ( Cover), alleviation, improvement or suppression.
- the skin film forming agent of the present invention can form a film on the skin to protect the skin from external irritation.
- the skin coating agent of the present invention may be provided in a conventional cosmetic formulation.
- the formulation may be a liquid, gel, foam, spray, mousse, ointment, cream, emulsion, suspension, lotion, milk, solid paste or semisolid paste.
- Second agent of Comparative Example 1 (catalyst formulation)
- the components 1 to 3 in the following table were sufficiently stirred and mixed at 1,000 rpm (mixture B), and the solution mixed with the components 4 to 7 in another container was slowly introduced into the mixture B. Mix at 2,000 rpm with a homomixer. Finally, component 8 is added to complete the formulation.
- ingredients 1 to 2 in the table below were mixed until well mixed at 1,000 rpm. Add ingredients 4-5 sequentially to make them uniform, then slowly add ingredients 3 and mix until no particles are visible (mixture C). After mixing the ingredients 6 ⁇ 7 in another container, slowly add to the mixture C and mix to mix evenly.
- Example 2 Second agent of Example 1 (catalyst formulation)
- the components 1 to 3 shown in the following table were sufficiently stirred and mixed at 1,000 rpm (mixture D), and the solution containing the components 4 to 7 mixed in another container was slowly added to the mixture D. Mix at 2,000 rpm with a homomixer. Finally, component 8 is added to complete the formulation.
- Comparative Example 1 and Example 1 prepared above were applied by mixing 1: 1.
- Comparative Example 1 and Example 1 prepared above After applying Comparative Example 1 and Example 1 prepared above to the skin was rubbed 10 times with a finger to confirm the sliding phenomenon of the film.
- the strength and elongation of the formulation prepared in the composition shown in the following table was measured.
- the strength of the coating is the strength at which the specimen breaks during the tensile test, and the elongation is the length of the coating until it is broken.
- the experiment was conducted in accordance with the ASTM D638 standard. The repeat test was repeated 15 times at 10 mm / s speed, and the tensile test was conducted at 10 mm / s speed. The experimental results are shown in the table below and FIG. 3.
- the 1st agent (silicone formulation) of each Example and the comparative example was manufactured with the composition of the following table.
- the 2nd agent (catalyst preparation) of each Example and the comparative example was manufactured with the composition of the following table.
- Example 2 Example 3 Example 4 Example 5 Comparative Example 2 Comparative Example 3 Encapsulation 2.53 3.50 4.63 4.37 2.35 2.40 wrinkle improvement 2.83 3.61 4.31 4.02 2.66 2.54 Jungle 4.20 4.31 4.45 4.41 3.01 3.33 Persistence 3.62 3.55 3.81 3.77 2.57 2.75
- Example 4 was as much as 97% higher than Comparative Example 2, and in the case of wrinkle improvement, Example 4 was 69.7% higher than Comparative Example 3, and all examples were compared in the case of denseness and persistence. 38% higher results than Example 2.
- the present invention provides a skin coating agent capable of forming a high-strength coating, eliminating peeling and slipping of the coating, and effectively improving skin disadvantages, in particular, wrinkles and elasticity, for various skin formulations containing the same. It can be used as a composition.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
구분 | 원료명 | 함량 (%) |
1 | 비닐 디메치콘(Vinyl Dimethicone) (165,000 cP)(Andisil ® VS 165,000) | 3.43 |
2 | 비닐 디메치콘(Vinyl Dimethicone) (10,000 cSt)(Andisil ® VS 10,000) | 14.61 |
3 | 하이드리드 디메치콘(Hydride Dimethicone) (45 cSt)(Andisil ® XL-11) | 7.16 |
4 | 표면 처리 실리카 (Surface treated silica)(Aerosil R8200) | 6.8 |
5 | 사이클로펜타실록 산(Cyclopentasiloxane) | 12.0 |
6 | 디메치콘/PEG-10/15 크로스폴리머 (Dimethicone/PEG-10/15 Crosspolymer) | 4.0 |
7 | 정제수 | 100으로 채움 |
8 | 1,2-헥사네디올 (1,2-Hexanediol) | 1.5 |
구분 | 원료명 | 함량 (%) |
1 | 디메치콘 크로스폴리머 (Dimethicone crosspolymer) | 10.0 |
2 | 디메치콘/PEG-10/15 크로스폴리머 (Dimethicone/PEG-10/15 Crosspolymer) | 4.0 |
3 | 사이클로펜타실록산 (Cyclopentasiloxane) | 15.8 |
4 | 정제수 | 63.2 |
5 | 염화나트륨 | 0.5 |
6 | 1,2-헥사네디올 (1,2-Hexanediol) | 1.5 |
7 | 글리세린 | 4.0 |
8 | Karstedt 백금 촉매 (solution 2% platinum) | 1.0 |
구분 | 원료명 | 함량 (%) |
1 | 디메치콘올 (Dimethiconol) (20,000 cP)(Andisil ® OH 20,000) | 15.0 |
2 | 하이드리드 디메치콘 (Hydride Dimethicone) (45 cSt)(Andisil ® X-10) | 7.0 |
3 | 표면 처리 실리카 (Surface treated silica)(Aerosil R8200) | 3.4 |
4 | 사이클로펜타실록산 (Cyclopentasiloxane) | 18.0 |
5 | 디메치콘/PEG-10/15 크로스폴리머 (Dimethicone/PEG-10/15 Crosspolymer) | 5.0 |
6 | 정제수 | 100으로 채움 |
7 | 1,2-헥사네디올 (1,2-Hexanediol) | 1.5 |
구분 | 원료명 | 함량 (%) |
1 | 디메치콘 크로스폴리머 (Dimethicone crosspolymer) | 10.0 |
2 | 디메치콘/PEG-10/15 크로스폴리머 (Dimethicone/PEG-10/15 Crosspolymer) | 4.0 |
3 | 사이클로펜타실록산 (Cyclopentasiloxane) | 15.8 |
4 | 정제수 | 63.2 |
5 | 염화나트륨 | 0.5 |
6 | 1,2-헥사네디올 (1,2-Hexanediol) | 0.5 |
7 | 글리세린 | 4.0 |
8 | Karstedt 백금 촉매 (solution 2% platinum) | 1.0 |
원료명 | 실험 1 | 실험 2 | 실험 3 | 실험 4 | 실험 5 | 실험 6 |
비닐 디메치콘 (1,000 cSt)(Andisil ® VS 1,000) | 6.00 g | - | - | - | - | - |
비닐 디메치콘 (10,000 cSt)(Andisil ® VS 10,000) | - | 6.00 g | - | - | - | - |
비닐 디메치콘 (65,000 cP)(Andisil ® VS 65,000) | - | - | 6.00 g | - | - | - |
디메치콘올 (2,000 cP)(Andisil ® OH 2,000) | - | - | - | 6.00 g | - | - |
디메치콘올 (20,000 cP)(Andisil ® OH 20,000) | - | - | - | - | 6.00 g | - |
디메치콘올 (80,000 cP)(Andisil ® OH 80,000) | - | - | - | - | - | 6.00 g |
하이드리드 디메치콘 (45 cSt) (Andisil ® XL 10) | 2.15 g | 2.15 g | 2.15 g | 2.15 g | 2.15 g | 2.15 g |
실험 1 | 실험 2 | 실험 3 | 실험 4 | 실험 5 | 실험 6 | |
강도(kPa) | 796.2 | 876.0 | 904.4 | 360.9 | 1467.7 | 3329.9 |
신율(%) | 150.7 | 350.0 | 446.1 | 116.2 | 558.9 | 672.0 |
구분 | 원료명 | 실시예 2 | 실시예 3 | 실시예 4 | 실시예 5 | 비교예 2 | 비교예 3 |
1 | 디메치콘올 (2,000 cP)(Andisil ® OH 2,000) | 15.0 | - | - | - | - | - |
2 | 디메치콘올 (20,000 cP)(Andisil ® OH 20,000) | - | 15.0 | - | 7.5 | - | - |
3 | 디메치콘올 (80,000 cP)(Andisil ® OH 80,000) | - | - | 15.0 | 7.5 | - | - |
4 | 비닐디메치콘 (1000 cSt)(Andisil ® VS1000) | - | - | - | - | 15.0 | 15.0 |
5 | 하이드리드 디메치콘(Andisil ® XL-11) (45 cSt, SiH 함량=4.85 mmol/g) | - | - | - | - | 7.0 | - |
6 | 하이드리드 디메치콘(Andisil ® XL-10)(45 cSt, SiH 함량=7.35 mmol/g) | 7.0 | 7.0 | 7.0 | 7.0 | - | 7.0 |
7 | 표면 처리 실리카 (Surface treated silica)(Aerosil R8212S) | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 |
8 | 사이클로펜타실록산(Cyclopentasiloxane) | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 | 18.0 |
9 | 디메치콘/PEG-10/15 크로스폴리머 (Dimethicone/PEG-10/15 Crosspolymer) | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 |
10 | 정제수 | 100으로 채움 | 100으로 채움 | 100으로 채움 | 100으로 채움 | 100으로 채움 | 100으로 채움 |
11 | 1,2-헥사네디올 (1,2-Hexanediol) | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 |
구분 | 원료명 | 함량 (%) |
1 | 디메치콘 크로스폴리머 (Dimethicone crosspolymer) | 10.0 |
2 | 디메치콘/PEG-10/15 크로스폴리머 (Dimethicone/PEG-10/15 Crosspolymer) | 4.0 |
3 | 비닐디메치콘 (1000 cSt) (Andisil ® VS1000) | 5.0 |
4 | 사이클로펜타실록산 (Cyclopentasiloxane) | 10.8 |
5 | 정제수 | 64.2 |
6 | 염화나트륨 | 0.5 |
7 | 1,2-헥사네디올 (1,2-Hexanediol) | 0.5 |
8 | 글리세린 | 4.0 |
9 | Karstedt 백금 촉매 (solution 2% platinum) | 1.0 |
실시예 2 | 실시예 3 | 실시예 4 | 실시예 5 | 비교예 2 | 비교예 3 | |
피막형성 | 2.53 | 3.50 | 4.63 | 4.37 | 2.35 | 2.40 |
주름개선 | 2.83 | 3.61 | 4.31 | 4.02 | 2.66 | 2.54 |
밀림성 | 4.20 | 4.31 | 4.45 | 4.41 | 3.01 | 3.33 |
지속성 | 3.62 | 3.55 | 3.81 | 3.77 | 2.57 | 2.75 |
Claims (15)
- 디메치콘올(Dimethiconol), 하이드리드 디메치콘(Hydride dimethicone) 및 가교성분을 포함하는 피부 피막 형성제.
- 제1항에 있어서,상기 피부 피막 형성제는 디메치콘올 및 하이드리드 디메치콘은 가교성분과 피부 도포에 앞서 공간적으로 분리 존재되어 접촉 상태가 방지되는 것을 특징으로 하는 피부 피막 형성제.
- 제1항에 있어서,상기 피부 피막 형성제는 i) 디메치콘올 및 하이드리드 디메치콘을 포함하는 제1제, 및 ii) 가교성분을 포함하는 제2제로 구성되고, 상기 제1제 및 제2제는 피부 도포에 직전에 혼합되어 피부에 도포되는 것을 특징으로 하는 피부 피막 형성제.
- 제1항에 있어서,상기 디메치콘올은 점도가 1000 내지 100000 cP 또는 cSt이고, 상기 하이드리드 디메치콘은 점도가 0.1 내지 1000 cP 또는 cSt인 것을 특징으로 하는 피부 피막 형성제.
- 제1항에 있어서,상기 피부 피막 형성제는 피부 피막 형성제 총 중량 대비 디메치콘올 0.1 내지 30%(w/w), 하이드리드 디메치콘 0.1 내지 15%(w/w) 포함하는 것을 특징으로 하는 피부 피막 형성제.
- 제1항에 있어서,상기 피부 피막 형성제는 디메치콘올 : 하이드리드 디메치콘 함량이 1 내지 4 : 1인 것을 특징으로 하는 피부 피막 형성제.
- 제1항에 있어서,상기 하이드리드 디메치콘은 최소 한 개 이상의 하이드리드 말단을 갖는 것을 특징으로 하는 피부 피막 형성제.
- 제1항에 있어서,상기 하이드리드 디메치콘의 SiH 함량은 1 내지 15 mmol/g 인 것을 특징으로 하는 피부 피막 형성제.
- 제1항에 있어서,상기 가교성분은 디메치콘올 및 하이드리드 디메치콘의 원위치 가교결합 반응을 촉매하는 것을 특징으로 하는 피부 피막 형성제.
- 제1항에 있어서,상기 피부 피막 형성제는 가교성분을 피부 피막 형성제 총 중량 대비 0.1 내지 5%(w/w) 포함하는 것을 특징으로 하는 피부 피막 형성제.
- 제10항에 있어서,상기 가교성분은 백금 촉매인 것을 특징으로 하는 피부 피막 형성제.
- 제11항에 있어서,상기 백금 촉매는 백금 카보닐 사이클로비닐메틸실록산 복합체, 백금 디비닐테트라메틸디실록산 복합체, 백금 사이클로비닐메틸실록산 복합체, 백금 옥탄알데하이드/옥탄올 복합체 및 이들의 조합물로 이루어진 군에서 선택되는 것을 특징으로 하는 피부 피막 형성제.
- 제1항에 있어서,상기 피부 피막 형성제는 표면 처리된 운모, 징크 옥사이드, 티타늄 디옥사이드, 알루미늄 옥사이드, 점토 및 실리카로 이루어진 군에서 선택된 어느 하나 이상을 추가로 포함하는 것을 특징으로 하는 피부 피막 형성제.
- 제13항에 있어서,상기 실리카는 헥사메틸디실라잔(Hexamethyldisilazane)으로 표면 처리된 것을 특징으로 하는 피부 피막 형성제.
- 제1항에 있어서,상기 피부 피막 형성제는 피부의 주름, 색소 침착, 검버섯, 모공 증가, 흉터, 탄력 감소, 늘어짐, 수분 감소 및 윤기 감소 중에서 선택된 어느 하나 이상의 피부 결함을 가리기(커버), 완화, 개선 또는 억제하는 것을 특징으로 하는 피부 피막 형성제.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/978,917 US11497704B2 (en) | 2018-03-09 | 2019-01-04 | Agent for forming film on skin |
CN201980016925.6A CN111818909B (zh) | 2018-03-09 | 2019-01-04 | 皮肤皮膜形成剂 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180028177A KR102202389B1 (ko) | 2018-03-09 | 2018-03-09 | 피부 피막 형성제 |
KR10-2018-0028177 | 2018-03-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019172517A1 true WO2019172517A1 (ko) | 2019-09-12 |
Family
ID=67846146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2019/000169 WO2019172517A1 (ko) | 2018-03-09 | 2019-01-04 | 피부 피막 형성제 |
Country Status (4)
Country | Link |
---|---|
US (1) | US11497704B2 (ko) |
KR (1) | KR102202389B1 (ko) |
CN (1) | CN111818909B (ko) |
WO (1) | WO2019172517A1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102500988B1 (ko) * | 2020-11-23 | 2023-02-21 | 주식회사 메가코스 | 반응성 실리콘을 포함하는 화장료 조성물 |
CN115177552A (zh) * | 2022-07-11 | 2022-10-14 | 杭州归领医疗器械有限公司 | 一种即时遮皱的仿生皮肤乳霜及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000067126A (ko) * | 1999-04-23 | 2000-11-15 | 서경배 | 활성성분의 안정화시키기 위해, 활성성분-함유 다공성 마이크로비드의 표면을 실리콘 또는 그 유도체로 박막처리하는 방법, 및 이러한 방법에 의해 실리콘-박막처리된 활성성분-함유 다공성 마이크로비드를 함유하는 화장료 또는 피부도포용 의약품 조성물 |
CN101627960A (zh) * | 2008-07-14 | 2010-01-20 | 孙海 | 一种柔滑的护肤乳液 |
WO2011143131A1 (en) * | 2010-05-11 | 2011-11-17 | Shaosheng Dong | Film forming personal care compositions and methods |
KR20130135843A (ko) * | 2010-08-31 | 2013-12-11 | 리빙 프루프 인코포레이티드 | 피부 조성물 및 이의 사용방법 |
WO2014101703A1 (en) * | 2012-12-24 | 2014-07-03 | Unilever N.V. | Cosmetic composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2793409B1 (fr) * | 1999-05-11 | 2004-03-19 | Oreal | Composition cosmetique comprenant une dispersion aqueuse de polymere filmogene et d'organopolysiloxane |
FR2894817B1 (fr) | 2005-12-20 | 2008-05-09 | Oreal | Procede de maquillage ou de soin des matieres keratiniques comprenant l'application de composes a et b dont l'un au moins est silicone |
ATE516795T1 (de) | 2008-02-12 | 2011-08-15 | Coty Germany Gmbh | Zweiteiliges kosmetikprodukt mit quelleffekt auf biologischen oberflächen |
EP2208494A1 (en) | 2009-01-15 | 2010-07-21 | Coty Deutschland GmbH | Antiperspirant stick composition |
FR3026300B1 (fr) | 2014-09-30 | 2020-01-10 | L'oreal | Procede cosmetique pour attenuer les rides |
-
2018
- 2018-03-09 KR KR1020180028177A patent/KR102202389B1/ko active IP Right Grant
-
2019
- 2019-01-04 CN CN201980016925.6A patent/CN111818909B/zh active Active
- 2019-01-04 WO PCT/KR2019/000169 patent/WO2019172517A1/ko active Application Filing
- 2019-01-04 US US16/978,917 patent/US11497704B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000067126A (ko) * | 1999-04-23 | 2000-11-15 | 서경배 | 활성성분의 안정화시키기 위해, 활성성분-함유 다공성 마이크로비드의 표면을 실리콘 또는 그 유도체로 박막처리하는 방법, 및 이러한 방법에 의해 실리콘-박막처리된 활성성분-함유 다공성 마이크로비드를 함유하는 화장료 또는 피부도포용 의약품 조성물 |
CN101627960A (zh) * | 2008-07-14 | 2010-01-20 | 孙海 | 一种柔滑的护肤乳液 |
WO2011143131A1 (en) * | 2010-05-11 | 2011-11-17 | Shaosheng Dong | Film forming personal care compositions and methods |
KR20130135843A (ko) * | 2010-08-31 | 2013-12-11 | 리빙 프루프 인코포레이티드 | 피부 조성물 및 이의 사용방법 |
WO2014101703A1 (en) * | 2012-12-24 | 2014-07-03 | Unilever N.V. | Cosmetic composition |
Also Published As
Publication number | Publication date |
---|---|
KR102202389B1 (ko) | 2021-01-12 |
CN111818909B (zh) | 2023-06-13 |
US11497704B2 (en) | 2022-11-15 |
US20210361556A1 (en) | 2021-11-25 |
CN111818909A (zh) | 2020-10-23 |
KR20190106548A (ko) | 2019-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2611413B1 (en) | Skin compositions and methods of use thereof | |
FI97684B (fi) | Kosmeettisissa koostumuksissa käytettäviä väliainesysteemejä | |
EP2793841B1 (en) | Composition comprising a specific acrylic polymer and a silicone copolymer, and method for treating keratin fibres using same | |
WO2019172517A1 (ko) | 피부 피막 형성제 | |
WO2017057862A1 (ko) | 묻어남이 개선된 메이크업 조성물 및 이의 제조 방법 | |
WO2017119612A1 (ko) | 필-오프타입 팩 화장료 조성물 및 이의 제조 방법 | |
CA2293800A1 (en) | Improved cosmetic composition containing ferulic acid esters | |
WO2018056652A1 (ko) | 유기 자외선 차단제가 담지된 실리카 에어로겔 복합체 | |
WO2018097584A1 (ko) | 수분산 타입 메이크업 화장료 조성물 | |
WO2016175524A1 (ko) | 모발의 건조 시간 단축 및 부드러움 개선을 위한 조성물 | |
KR20200000880A (ko) | 우수한 색상 지속력과 유연성을 가지는 입술용 메이크업 조성물 | |
WO2020218669A1 (ko) | 보습력이 향상된 마스크팩 조성물 | |
CN108623810B (zh) | 一种有机硅交联聚合物及其制备方法和应用 | |
KR20210015838A (ko) | 순수 그래핀, 천연 감압성 접착제(psa)를 함유하는 조성물, 및 피부에 적용하기 위한 방법 | |
WO2018056590A1 (ko) | 모발 컨디셔닝 조성물 | |
WO2020218670A1 (ko) | 주름개선력이 향상된 마스크팩 조성물 | |
WO2018101686A1 (ko) | 지속성이 우수한 유화 메이크업 화장료 조성물 및 화장료 조성물의 지속력 평가 방법 | |
KR102398165B1 (ko) | 가교된 폴리오가노실록산 및 이를 함유하는 퍼스널 케어 조성물 | |
WO2020145743A1 (ko) | 화장료용 에멀젼 조성물 및 이를 포함하는 화장료 조성물 | |
WO2022092768A1 (ko) | 무기분체를 안정적으로 내포하는 워터 드롭 매크로 에멀젼 화장료 조성물 및 이의 제조방법 | |
WO2017043774A1 (ko) | 소수성 실리카를 포함하는 자가 탄성 복원용 메이크업 화장료 조성물 및 그의 제조방법 | |
WO2022124079A1 (ja) | 白金触媒を含む水中油型乳化組成物、及びその使用方法 | |
KR20210116739A (ko) | 반응성 실리콘을 포함하는 다공성 동결건조물 형태의 화장료 조성물 | |
WO2017003174A1 (ko) | 발림성이 우수한 수중유형 화장료 조성물 | |
WO2023158261A1 (ko) | 묻어남을 개선한 수중유형 입술용 화장료 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19764560 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19764560 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 14.04.2021) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19764560 Country of ref document: EP Kind code of ref document: A1 |